LONDON, 15 March 2022 – Bryan, Garnier & Co, the leading independent investment bank for European healthcare and technology companies has elected two partners and made 11 Managing Director promotions across the firm.
The newly elected partners are Clifford Siegel, Chairman of Bryan Garnier and Christophe Alleman, Co-Head of the firm’s Equity Capital Markets team.
Olivier Garnier, Managing Partner of Bryan Garnier said: “We are delighted to welcome both Cliff and Christophe to the partnership this year, following a landmark year for our firm. We are also pleased to announce the promotion of 11 new Managing Directors. We look forward to their ongoing success at Bryan, Garnier & Co as they continue to provide outstanding results for clients, driven by sector-specialist knowledge and flawless deal execution capabilities supported by our full-service platform.”
About Bryan, Garnier & Co
Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors. Clients benefit from our relentless commitment to their long-term success, unparalleled insights into these strategically important sectors and strong relationships with investors – from private equity and venture capital to institutional investors across the US, Europe, and Asia.
Our corporate clients operate in high growth, fast moving sectors and many are disruptors focused on solving some of the most important sustainability challenges facing the world today. As a sector driven investment bank, our advice is rooted in deep industry knowledge with a global perspective, and clients benefit from our full-service platform and product expertise that will accelerate their long-term success.
We partner with clients for the long term throughout their lifecycle, providing them with ideas, access to public and private capital and M&A advisory with flawless execution. Our highly experienced equity research team thinks beyond the obvious to provide compelling and differentiated insights and investment themes to our corporate and investor clients, giving them that important competitive edge.
Our independence and entrepreneurial culture, which come from being a 25-year-old partnership ensure complete alignment with our clients. Our purpose, which is to help European pioneers become global champions, has been constant since the bank’s foundation 25 years ago and remains why clients continue to choose Bryan Garnier as their partner for the long term.
New Managing Directors
Software
New Managing Director
Industrial Tech
New Managing Directors
Healthcare
New Managing Director
Energy Transition & Sustainability
New Managing Director
Business & Tech-enabled Services
New Managing Director
Equity Capital Market
New Managing Director
Equity Research
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European growth investment bank that helps healthcare and technology companies become global champions. By combining extensive sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and privileged access to buyers and capital in Europe, the US and Asia.
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan Garnier & Co is an independent partnership with around 200 employees located in major financial centres in Europe and the US.